HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Novartis Tavist ND Loratadine Tablets Carry Geneva’s Marketing Exclusivity

This article was originally published in The Tan Sheet

Executive Summary

Geneva Pharmaceuticals initially will market the first generic competition to Schering-Plough's OTC Claritin behind pharmacy counters

You may also be interested in...

Novartis Omeprazole Offering, Wellpoint, Prilosec OTC Pressure PPI Prices

Novartis' entrance into the OTC loratadine market in March could set a precedent for the firm to make a similar move with the proton pump inhibitor omeprazole

Robitussin CoughGels Dedicated Ads Planned During Cough/Cold Season

Robitussin CoughGels will join Wyeth Consumer Care's established line of cough/cold products on shelves in time for the fall/winter 2003 season, the firm said at the recent National Association of Chain Drug Stores Marketplace show in San Diego

Novartis Triaminic Allerchews With Loratadine Slated To Launch In 2004

Novartis' Triaminic children's cough/coldline will be extended in early 2004 with Allerchews, the brand's first loratadine-containing offering. The product debuted at the National Association of Chain Drug Stores Marketplace in San Diego June 8-10

Related Content


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts